(Q36828546)

16 August 2017

1 reference

title

Design of new anti-viral agents for chronic hepatitis B virus infection (English)

1 reference

16 August 2017

1 reference

1 reference

1 reference

Locarnini S

1

1 reference

16 August 2017

publication date

1 January 1991

1 reference

Journal of Gastroenterology and Hepatology

16 August 2017

published in

1 reference

16 August 2017

volume

6 Suppl 1

1 reference

16 August 2017

page(s)

18-22

1 reference

Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01161.X

Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01161.X

Screening of antiviral drugs for hepadna virus infection in Pekin ducks: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01161.X

Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis B virus in chronic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01161.X

Effect of Phyllanthus amarus on duck hepatitis B virus replication in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01161.X

In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01161.X

Effect of 3'-azido-3'-deoxythymidine on replication of duck hepatitis B virus in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01161.X

Preliminary evidence that azidothymidine does not affect hepatitis B virus replication in acquired immunodeficiency syndrome (AIDS) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01161.X

Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01161.X

Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01161.X

Foscarnet therapy in chronic hepatitis B virus E antigen carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01161.X

Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01161.X

Antiviral strategies in chronic hepatitis B virus infection: I. Establishment of an in vitro system using the duck hepatitis B virus model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01161.X

Topoisomerases in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01161.X

Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01161.X

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB01161.X

10.1111/J.1440-1746.1991.TB01161.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference